Connecting you to content on EBSCOhost

Works matching IS 14628732 AND DT 2021 AND VI 26 AND IP 4

Results: 7

1

Drug Repositioning as a Pharmaceutical Strategy: The Obvious Benefits are Real but Beware of Pitfalls That May be Less Apparent.

Published in:

Journal of Commercial Biotechnology, 2021, v. 26, n. 4, p. 89, doi. 10.5912/jcb1011

By:

Reaume, Andrew G.

Publication type:

Article

2

The Role of the Biotechnology Industry in Addressing Health Inequities in Africa: Strengthening the Entire Health Care Value Chain.

Published in:

Journal of Commercial Biotechnology, 2021, v. 26, n. 4, p. 50, doi. 10.5912/jcb1008

By:

Sammut, Stephen M.

Publication type:

Article

3

Strategic Alliance and Acquisition Performance: Impact of Interfirm Synergies and Motives in the Bio-Pharmaceutical Industry.

Published in:

Journal of Commercial Biotechnology, 2021, v. 26, n. 4, p. 37, doi. 10.5912/jcb1007

By:

Jambulingam, Thani;
Saxton, Todd

Publication type:

Article

4

Considerations for Potential Global Expansion of Serum Institute of India.

Published in:

Journal of Commercial Biotechnology, 2021, v. 26, n. 4, p. 26, doi. 10.5912/jcb1006

By:

Somasundaram, Veena;
Soukas, Peter;
Patel, Jenish;
Ferguson, Steven

Publication type:

Article

5

Australian Biotechnology: A 10-Year Study of Investor Performance.

Published in:

Journal of Commercial Biotechnology, 2021, v. 26, n. 4, p. 16, doi. 10.5912/jcb1005

By:

Molloy, Peter L.;
Johnson, Lester W.;
Gilding, Michael

Publication type:

Article

6

"A Conversation on How we can Accelerate Innovation in Biopharma and Life Sciences Through Global Collaborations and Alliances".

Published in:

Journal of Commercial Biotechnology, 2021, v. 26, n. 4, p. 5, doi. 10.5912/jcb1004

By:

Boni, Arthur A.;
Molloy, Peter I.

Publication type:

Article

7

A Note From the Editor in Chief.

Published in:: Journal of Commercial Biotechnology, 2021, v. 26, n. 4, p. 3, doi. 10.5912/jcb1003
Publication type:: Article